Background/Aims: Seasonal variation in lipid levels is well described in the general population, but has not been examined in renal transplant recipients (RTR). We sought to determine whether seasonal differences exist in RTR, a group at high risk for hyperlipidemia. Methods: We reviewed our population of 920 adults, identifying primary allograft recipients with survival ≧1 year, stable function, and ≧1 pair of post-6 months ‘winter’ (December 21 to March 20) plus ‘summer’ (June 21 to September 22) fasting lipid measurements within the same year. Correlations between factors affecting lipids and lipid level change were followed by multiple linear regression analysis. Results: 243 patients contributed 344 pairs. When most recent seasonal pair (n = 243) and all pairs (n = 344) were separately analyzed, no seasonal total cholesterol difference (winter vs. summer) was seen (5.08 vs. 5.05 mmol/l, p = 0.80; 5.11 vs. 5.09 mmol/l, p = 0.81 respectively). Opposing variation was seen between hyperlipidemic and nonhyperlipidemic patients (0.08 vs. –0.18 mmol/l for winter minus summer, p = 0.02). In multivariate analysis, seasonal cholesterol variation was predicted by level (p < 0.0001) and hemoglobin change (p = 0.01), while triglyceride variation was predicted only by level (p = 0.01). Conclusion: RTR do not exhibit seasonal variation in lipids, unlike the general population. Factors unique to RTR such as immunosuppressive therapies may act to suppress any seasonal effects.

1.
Ahlbom A: Seasonal variations in the incidence of acute myocardial infarction in Stockholm. Scand J Soc Med 1979;7:127–130.
2.
Douglas AS, Dunnigan MG, Allan TM, Rawles JM: Seasonal variation in coronary heart disease in Scotland. J Epidemiol Comm Health 1995;49:575–582.
3.
Enqueslassie F, Dobson AJ, Alexander HM, Steele PL: Seasons, temperature and coronary heart disease. Int J Epidemiol 1993;22:632–636.
4.
Manfredini R, Boari B: Seasonal variation in serum cholesterol levels: Another piece in the puzzle of the winter excess in cardiovascular deaths? Arch Intern Med 2004;164:2505–2506.
5.
Thomas C, Holljes H, Eisenberg F: Observations on seasonal variations in total serum cholesterol level among healthy young prisoners. Ann Intern Med 1961;54:413–430.
6.
Fyfe T, Dunnigan M, Hamilton E, Rae R: Seasonal variation in serum lipids, and incidence and mortality of ischemic heart disease. J Atheroscler Res 1968;8:591–596.
7.
Buxtorf JC, Baudet MF, Martin C, Richard JL, Jacotot B: Seasonal variations of serum lipids and apoproteins. Ann Nutr Metab 1988;32:68–74.
8.
Cucu F, Purice S, Schioiu-Costache L, Damsa T, Suciu A, Cherciu A, Steinbach M: Seasonal variations of serum cholesterol detected in the Bucharest Multifactorial Prevention Trial of Coronary Heart Disease: ten years follow-up (1971–1982). Rom J Intern Med 1991;29:15–21.
9.
Rastam L, Hannan PJ, Luepker RV, Mittelmark MB, Murray DM, Slater JS: Seasonal variation in plasma cholesterol distributions: implications for screening and referral. Am J Prev Med 1992;8:360–366.
10.
Gordon DJ, Hyde J, Trost DC, Whaley FS, Hannan PJ, Jacobs DR, Ekelund LG: Cyclic seasonal variation in plasma lipid and lipoprotein levels: the Lipid Research Clinics Coronary Prevention Trial Placebo Group. J Clin Epidemiol 1988;41:679–689.
11.
Ockene IS, Chiriboga DE, Stanek EJ III, Harmatz MG, Nicolosi R, Saperia G, Well AD, Freedson P, Merriam PA, Reed G, Ma Y, Matthews CE, Hebert JR: Seasonal variation in serum cholesterol levels: treatment implications and possible mechanisms. Arch Intern Med 2004;164:863–870.
12.
Kovacic V, Kovacic V: Seasonal variations of clinical and biochemical parameters in chronic haemodialysis. Ann Acad Med Singapore 2004;33:763–768.
13.
Prasad GV, Nash MM, Zaltzman JS: Seasonal variation in outpatient blood pressure in stable renal transplant recipients. Transplantation 2001;72:1792–1794.
14.
Becker DM, Markakis M, Sension M, Vitalis S, Baughman K, Swank R, Kwiterovich PO, Pearson TA, Achuff SG, Baumgartner WA: Prevalence of hyperlipidemia in heart transplant recipients. Transplantation 1987;44:323–325.
15.
Markell MS, Brown CD, Butt KMH, Friedman EA: Prospective evaluation of changes in lipid profiles in cyclosporine treated renal transplant patients. Transplant Proc 1989;21:1497–1499.
16.
Drueke TB, Abdulmassih Z, Lacour B, Bader C, Chevalier A, Kreis H: Atherosclerosis and lipid disorders after renal transplantation. Kidney Int 1991;39(suppl 31):S24–S28.
17.
Vathsala A, Weinberg RB, Schoenberg L, Grevel J, Goldstein RA, Van Buren CT, Lewis RM, Kahan BD: Lipid abnormalities in cyclosporine-prednisone treated renal transplant recipients. Transplantation 1989;1:37–43.
18.
Morrisett JD, Abdel-Fattah G, Hoogeveen R, Mitchell E, Ballantyne CM, Pownall HJ, Opekun AR, Jaffe JA, Oppermann S, Kahan BD: Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients, J Lipid Res 2002;43:1170–1180.
19.
Argani H, Javanshir MR: Seasonal variation of blood pressure in hemodialysis and renal transplant recipients. Transplant Proc 2004;36:148–149.
20.
Kobashigawa JA, Kasiske BL: Hyperlipidemia in solid organ transplantation. Transplantation 1997;63:331–338.
21.
Holdaas H, Fellstrom B, Jardine AG, Holme I, Nyberg G, Fauchald P, Gronhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambuhl P, Olsson AG, Hartmann A, Solbu DO, Pedersen TR: Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomized, placebo-controlled trial. Lancet 2003;361:2024–2031.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.